Literature DB >> 25860078

Role of triggering receptor expressed on myeloid cells-1/3 in Klebsiella-derived pneumosepsis.

Tijmen J Hommes1,2, Mark C Dessing3, Cornelis van 't Veer1,2, Sandrine Florquin3, Marco Colonna4, Alex F de Vos1,2, Tom van der Poll1,2,5.   

Abstract

Triggering receptor expressed on myeloid cells (TREM)-1 and -2 can affect Toll-like receptor-mediated activation of immune cells. Klebsiella pneumoniae is a common cause of pneumonia-derived sepsis. Here we studied the role of TREM-1/3 and TREM-2 in the host response during Klebsiella pneumonia. Macrophages lacking either TREM-1/3 or TREM-2 were tested for their responsiveness toward K. pneumoniae and for their capacity to internalize this pathogen in vitro. TREM-1/3- and TREM-2-deficient mice were infected with K. pneumoniae via the airways, and their responses were compared with those in wild-type mice. TREM-1/3-deficient macrophages produced lower cytokine levels upon exposure to K. pneumoniae, whereas TREM-2-deficient macrophages released higher cytokine concentrations. TREM-2-deficient, but not TREM-1/3-deficient, macrophages showed a reduced capacity to phagocytose K. pneumoniae. TREM-1/3-deficient mice showed an impaired host defense during Klebsiella pneumonia, as reflected by worsened survival and increased bacterial growth and dissemination. In contrast, TREM-2 deficiency did not affect disease outcome. Although TREM-1/3 and TREM-2 influence macrophage responsiveness to K. pneumoniae in vitro, only TREM-1/3 contribute to the host response during Klebsiella pneumonia in vivo, serving a protective role.

Entities:  

Keywords:  Klebsiella pneumoniae; TREM-1; TREM-2; macrophages; pneumonia

Mesh:

Substances:

Year:  2015        PMID: 25860078     DOI: 10.1165/rcmb.2014-0485OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  9 in total

1.  TREM-1-accentuated lung injury via miR-155 is inhibited by LP17 nanomedicine.

Authors:  Zhihong Yuan; Mansoor Syed; Dipti Panchal; Myungsoo Joo; Chetna Bedi; Sokbee Lim; Hayat Onyuksel; Israel Rubinstein; Marco Colonna; Ruxana T Sadikot
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-12-18       Impact factor: 5.464

Review 2.  TREM-1 Modulation Strategies for Sepsis.

Authors:  Sara Siskind; Max Brenner; Ping Wang
Journal:  Front Immunol       Date:  2022-06-15       Impact factor: 8.786

3.  Effect of TREM-1 blockade and single nucleotide variants in experimental renal injury and kidney transplantation.

Authors:  Alessandra Tammaro; Jesper Kers; Diba Emal; Ingrid Stroo; Gwendoline J D Teske; Loes M Butter; Nike Claessen; Jeffrey Damman; Marc Derive; Gerjan J Navis; Sandrine Florquin; Jaklien C Leemans; Mark C Dessing
Journal:  Sci Rep       Date:  2016-12-08       Impact factor: 4.379

4.  Divergent Neuroinflammatory Regulation of Microglial TREM Expression and Involvement of NF-κB.

Authors:  Rosie Owens; Kathleen Grabert; Claire L Davies; Alessio Alfieri; Jack P Antel; Luke M Healy; Barry W McColl
Journal:  Front Cell Neurosci       Date:  2017-03-02       Impact factor: 5.505

5.  Primary macrophages and J774 cells respond differently to infection with Mycobacterium tuberculosis.

Authors:  Nuria Andreu; Jody Phelan; Paola F de Sessions; Jacqueline M Cliff; Taane G Clark; Martin L Hibberd
Journal:  Sci Rep       Date:  2017-02-08       Impact factor: 4.379

6.  TREM1 regulates antifungal immune responses in invasive pulmonary aspergillosis.

Authors:  L Bernal-Martínez; S M Gonçalves; B de Andres; C Cunha; I Gonzalez Jimenez; K Lagrou; E Mellado; M L Gaspar; J A Maertens; A Carvalho; L Alcazar-Fuoli
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

7.  sTREM-1 Predicts Disease Severity and Mortality in COVID-19 Patients: Involvement of Peripheral Blood Leukocytes and MMP-8 Activity.

Authors:  Pedro V da Silva-Neto; Jonatan C S de Carvalho; Vinícius E Pimentel; Malena M Pérez; Diana M Toro; Thais F C Fraga-Silva; Carlos A Fuzo; Camilla N S Oliveira; Lilian C Rodrigues; Jamille G M Argolo; Ingryd Carmona-Garcia; Nicola T Neto; Camila O S Souza; Talita M Fernandes; Victor A F Bastos; Augusto M Degiovani; Leticia F Constant; Fátima M Ostini; Marley R Feitosa; Rogerio S Parra; Fernando C Vilar; Gilberto G Gaspar; José J R da Rocha; Omar Feres; Fabiani G Frantz; Raquel F Gerlach; Sandra R Maruyama; Elisa M S Russo; Angelina L Viana; Ana P M Fernandes; Isabel K F M Santos; Vânia L D Bonato; Antonio L Boechat; Adriana Malheiro; Ruxana T Sadikot; Marcelo Dias-Baruffi; Cristina R B Cardoso; Lúcia H Faccioli; Carlos A Sorgi
Journal:  Viruses       Date:  2021-12-15       Impact factor: 5.048

8.  Reversal of TREM-1 ectodomain shedding and improved bacterial clearance by intranasal metalloproteinase inhibitors.

Authors:  G Weiss; C Lai; M E Fife; A M Grabiec; B Tildy; R J Snelgrove; G Xin; C M Lloyd; T Hussell
Journal:  Mucosal Immunol       Date:  2016-12-14       Impact factor: 7.313

9.  Association of Myeloid Liver Kinase B1 Depletion With a Reduction in Alveolar Macrophage Numbers and an Impaired Host Defense During Gram-Negative Pneumonia.

Authors:  Natasja A Otto; Alex F de Vos; Jeroen W J van Heijst; Joris J T H Roelofs; Tom van der Poll
Journal:  J Infect Dis       Date:  2022-04-01       Impact factor: 5.226

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.